Meibomian gland atrophy in children with allergic conjunctivitis.

IF 1.9 4区 医学 Q2 OPHTHALMOLOGY
International journal of ophthalmology Pub Date : 2025-05-18 eCollection Date: 2025-01-01 DOI:10.18240/ijo.2025.05.07
Wen-Fang He, Yi-Ping Wu, Jing-Wei Zheng, Bin-Ge Huang, Jing-Jing Zuo, Jin-Yang Li, Dan Jiang, Hui-Xiang Ma
{"title":"Meibomian gland atrophy in children with allergic conjunctivitis.","authors":"Wen-Fang He, Yi-Ping Wu, Jing-Wei Zheng, Bin-Ge Huang, Jing-Jing Zuo, Jin-Yang Li, Dan Jiang, Hui-Xiang Ma","doi":"10.18240/ijo.2025.05.07","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To investigate the factors influencing meibomian gland atrophy (MGA) in children with allergic conjunctivitis (AC).</p><p><strong>Methods: </strong>In this cross-sectional study, 60 children with AC aged 6-17y and 20 age-matched children without signs or symptoms of ocular surface dysfunction were included. Information on the duration of AC, untreated time, electronic screen time (EST), outdoor exercise time, body mass index (BMI), and frequency of eye rubbing was collected using a health history form. The Standard Patient Evaluation of Eye Dryness (SPEED) score was used for dry eye assessment. Images of the meibomian glands (MGs) were obtained using Keratograph 5M, and the rate of meibomian gland atrophy (MGAR) was calculated using Image J. All subjects underwent routine eye examinations.</p><p><strong>Results: </strong>The average age of the AC group was 10.43±2.75y (range 6-17y) and 10.35±3.42y (range 6-14y) in the control group. The MGAR in the AC group was 33.42%±11.91%, significantly higher than that in the control group (18.10%±11.74%, <i>P</i><0.001). Moreover, the MGAR in younger children (aged 12 and below) was significantly higher than in older children (<i>P</i><0.05). Multi-factor linear regression analysis revealed that EST non-projector was a risk factor for MGAR (<i>β</i>=0.332, 95%CI 0.04-0.22, <i>P</i>=0.004), while outdoor exercise time was a protective factor against MGAR (<i>β</i>=-0.407, 95%CI -0.39 to -0.10, <i>P</i>=0.001). The untreated time of AC was identified as a risk factor for MGAR (<i>β</i>=0.24, 95%CI 0.07-1.98, <i>P</i>=0.037), and the frequency of eye rubbing was associated with MG distortion score (<i>P</i>=0.00).</p><p><strong>Conclusion: </strong>Children with AC exhibit exacerbate MGA, with the degree of atrophy worsening as the untreated time of AC prolongs. Children under 12 years old show a higher MGAR, and EST non-projector negatively impacts MGA, while increased outdoor exercise time acts as a protective factor against MGA.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 5","pages":"832-839"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043294/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.05.07","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To investigate the factors influencing meibomian gland atrophy (MGA) in children with allergic conjunctivitis (AC).

Methods: In this cross-sectional study, 60 children with AC aged 6-17y and 20 age-matched children without signs or symptoms of ocular surface dysfunction were included. Information on the duration of AC, untreated time, electronic screen time (EST), outdoor exercise time, body mass index (BMI), and frequency of eye rubbing was collected using a health history form. The Standard Patient Evaluation of Eye Dryness (SPEED) score was used for dry eye assessment. Images of the meibomian glands (MGs) were obtained using Keratograph 5M, and the rate of meibomian gland atrophy (MGAR) was calculated using Image J. All subjects underwent routine eye examinations.

Results: The average age of the AC group was 10.43±2.75y (range 6-17y) and 10.35±3.42y (range 6-14y) in the control group. The MGAR in the AC group was 33.42%±11.91%, significantly higher than that in the control group (18.10%±11.74%, P<0.001). Moreover, the MGAR in younger children (aged 12 and below) was significantly higher than in older children (P<0.05). Multi-factor linear regression analysis revealed that EST non-projector was a risk factor for MGAR (β=0.332, 95%CI 0.04-0.22, P=0.004), while outdoor exercise time was a protective factor against MGAR (β=-0.407, 95%CI -0.39 to -0.10, P=0.001). The untreated time of AC was identified as a risk factor for MGAR (β=0.24, 95%CI 0.07-1.98, P=0.037), and the frequency of eye rubbing was associated with MG distortion score (P=0.00).

Conclusion: Children with AC exhibit exacerbate MGA, with the degree of atrophy worsening as the untreated time of AC prolongs. Children under 12 years old show a higher MGAR, and EST non-projector negatively impacts MGA, while increased outdoor exercise time acts as a protective factor against MGA.

过敏性结膜炎患儿睑板腺萎缩。
目的:探讨过敏性结膜炎(AC)患儿睑板腺萎缩(MGA)的影响因素。方法:在这项横断面研究中,60名6-17岁的AC儿童和20名年龄匹配的无眼表功能障碍体征或症状的儿童。使用健康史表格收集交流持续时间、未治疗时间、电子屏幕时间(EST)、户外运动时间、体重指数(BMI)和揉眼频率等信息。使用标准患者眼干度评估(SPEED)评分进行干眼症评估。采用角膜摄影术5M获取睑板腺(MGs)图像,并用图像j计算睑板腺萎缩率(MGAR)。结果:AC组患者平均年龄为10.43±2.75岁(范围6 ~ 17y),对照组平均年龄为10.35±3.42岁(范围6 ~ 14y)。AC组MGAR为33.42%±11.91%,显著高于对照组(18.10%±11.74%,PPβ=0.332, 95%CI 0.04 ~ 0.22, P=0.004),户外运动时间是预防MGAR的保护因素(β=-0.407, 95%CI -0.39 ~ -0.10, P=0.001)。AC治疗时间是MGAR发生的危险因素(β=0.24, 95%CI 0.07 ~ 1.98, P=0.037),揉眼频率与MG变形评分相关(P=0.00)。结论:AC患儿MGA加重,随着AC治疗时间的延长,萎缩程度加重。12岁以下儿童MGA较高,EST非投影仪对MGA有负向影响,而增加户外运动时间对MGA有保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
7.10%
发文量
3141
审稿时长
4-8 weeks
期刊介绍: · International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online). This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166. IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO); Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering. International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al. Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society). Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press). Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). Associate Editors-in-Chief include: Prof. Ning-Li Wang (President Elect of APAO); Prof. Ke Yao (President of Chinese Ophthalmological Society) ; Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ; Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA); Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society); Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA); Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA). IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles, both basic and clinical papers. Instruction is Welcome Contribution is Welcome Citation is Welcome Cooperation organization International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信